Rare diseases
Investigational molecules
Locations
Back to Germany1 286 clinical trials in Aachen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer
AustriaStudy on Treatment Options for Patients with Oligometastatic Pancreatic Cancer: Comparing Oxaliplatin, Fluorouracil, Folinic Acid, and Drug Combination
GermanyLong-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer
GermanyStudy on Fish Oil Emulsion for Preventing Atrial Fibrillation in High-Risk Cardiac Surgery Patients
GermanyStudy on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis
GermanyStudy on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy
The NetherlandsStudy on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT
AustriaStudy on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia
GermanyStudy Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer
GermanyStudy on Tasquinimod for Patients with Myelofibrosis Who Are Refractory or Intolerant to JAK2 Inhibitors
GermanyStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy
GermanyStudy Comparing Venetoclax and Azacitidine with Standard Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients with NPM1 Mutations Eligible for Intensive Treatment
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma treatments and various forms of breast cancer therapies, including studies of novel immunotherapy combinations for head and neck cancers.
Advanced therapeutic approaches including targeted treatments and combination therapies are being evaluated for improved patient outcomes.
Research targeting heart failure prevention and management of cardiovascular complications, with emphasis on innovative drug combinations and preventive treatments.
Studies focus on reducing cardiovascular events and improving long-term patient outcomes.
Clinical investigations addressing various chronic conditions, including inflammatory diseases and dermatological disorders.
Evaluating new therapeutic approaches for managing long-term conditions and improving quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
